Dina Ziada
Tanta University
H-index: 17
Africa-Egypt
Top articles of Dina Ziada
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Evaluation of hepatic fibrosis by transient elastography in βthalassemia children before and after hematopoietic stem cell transplantation | The Egyptian Journal of Haematology | Reem Salama Eslam Elhawary Dina Ziada Mohamed Elshanshory Asmaa Elkaffas | 2023/7/1 |
TREATMENT OF HEPATITIS C WITH DIRECT ACTING ANTIVIRAL DRUGS CAN PROTECT AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 INFECTION | United European Gastroenterology Journal | M Alboraie A Cordie W Ismail A Abu-Elfatth D Ziada | 2021 |
Evolution of liver fibrosis after interferon-based anti-hepatitis C virus therapy failure in 3,049 chronic hepatitis C patients without cirrhosis | Arab Journal of Gastroenterology | Heba Omar Imam Waked Wafaa Elakel Rabab Salama Wael Abdel-Razik | 2023/2/1 |
Comparative Study between Responders and Non Responders Among Patients Treated for Hepatitis C virus Infection | Benha medical journal | Amr Elhammadi Dina Ziada Wael Farrag | 2022/7/1 |
The Effect of a Hypocaloric Diet Containing Olive Oil on Hepatic Steatosis Grading Using Tissue Elastography: A Randomized Controlled Trial | Afro-Egyptian Journal of Infectious and Endemic Diseases | Wafaa Keshk Dina Ziada Samah Soliman Ferial EL-Kalla | 2022/3/1 |
Study of hepatitis B core-related antigen as a predictor marker of hepatocellular carcinoma in patients with chronic hepatitis B | Tanta Medical Journal | A-ZA Yousri Fatma Sarah MA Hamam Dina H Ziada Amany M Abo-El Enein | 2022/1/1 |
The effect of HCV eradication after direct-acting antiviral agents on hepatic steatosis: a prospective observational study | Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) | Hanan Soliman Dina Ziada Manal Hamisa Rehab Badawi Nehad Hawash | 2022/1/1 |
MRI with diffusion-weighted image in assessment of hepatic fibrosis and steatosis | Tanta Medical Journal | Nahla K Ali Elkholy Kareem M Ramadan Dina H Ziada Mohamed M Hefeda | 2022/7/1 |
Diagnostic Study of Serum Dickkopf 1 Level and Alpha Fetoprotein L3 as Tumor Biomarkers in Hepatocellular Carcinoma | Journal of Advances in Medicine and Medical Research | Amira Mohamed El Sharkawy Mohammed Hosny Fouda Dina Hazem Ziada Gihan Farouk Attia | 2022/7/1 |
The Correlation Between the Autotaxin Enzyme and Pruritus in Egyptian Patients Suffering from Chronic Liver Disease | Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents) | Fathia Asal Dina Ziada Ayman Wageh Mohammed El-Kohy Nehad Hawash | 2021/9/1 |
Serum markers as a predictor of hepatic fibrosis compared to fibroscan in chronic hepatitis B infected egyptian patients: a cross-sectional study | The Open Biomarkers Journal | Rehab Badawi Hanan Soliman Dina Ziada Mohammed Elhendawy Sherief Abd-Elsalam | 2020/11/5 |
Hemodynamic changes of hepatic & renal vessels in systemic bacterial infection with fever in HCV related cirrhosis | Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) | Eman M Helal Mohamed Sharaf-Eldin Abdel Raouf Abou El Azm Nagwa Mansour Badr Eldin Mohammed Mahmoud Dawoud | 2020/8/1 |
Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: a pilot study | International Immunopharmacology | Muhammad Tarek Abdel Ghafar Morad Ahmed Morad Enas A El-Zamarany Dina Ziada Hanan Soliman | 2020/5/1 |
Predictors for fibrosis regression in chronic HCV patients after the treatment with DAAS: results of a real-world cohort study | Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) | Hanan Soliman Dina Ziada Marwa Salama Manal Hamisa Rehab Badawi | 2020/2/1 |
The effect of genetic variations on ribavirin pharmacokinetics and treatment response in HCV-4 Egyptian patients receiving sofosbuvir/daclatasvir and ribavirin | Biomedicine & Pharmacotherapy | KS Abdelkawy SM El-Haggar DH Ziada NF Ebaid MA El-Magd | 2020/1/1 |
